Miracle Regeneratives

Miracle Regeneratives is a biotechnology company dedicated to bringing regenerative medicine cures to people with serious diseases. The company is pioneering the commercialization of a breakthrough technology developed at Baylor College of Medicine that enables regeneration of bile ducts in liver diseases, offering hope beyond symptom management and toward true healing.

At the heart of Miracle’s mission is a commitment to bring spiritual light and integrity to an industry often marked by greed and corruption. The company plans to provide doses of its therapy to underserved communities that cannot afford the high cost of gene therapy, aligning with its values without compromising investor confidence. In addition, Miracle aims to create open-source scientific datasets—such as single-cell sequencing atlases for key diseases—to advance global research efforts, ensuring that even if a therapy fails, the knowledge gained contributes to future cures.